(Q34734876)

4 August 2017

1 reference

title

Safety and tolerability of eprosartan in combination with hydrochlorothiazide (English)

1 reference

4 August 2017

1 reference

Michael Böhm

1

1 reference

4 August 2017

Alisia Sachse

series ordinal

2

1 reference

4 August 2017

publication date

1 January 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

25

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

599-611

1 reference

Choosing initial antihypertensive drug therapy for the uncomplicated hypertensive patient

4 August 2017

cites work

1 reference

12 December 2020

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

12 December 2020

The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group

1 reference

12 December 2020

Tolerability, safety, and quality of life and hypertensive therapy: the case for low-dose diuretics

1 reference

12 December 2020

Effects of Eprosartan Versus Enalapril in Hypertensive Patients on the Renin-Angiotensin-Aldosterone System and Safety Parameters: Results from a 26-Week, Double-blind, Multicentre Study

1 reference

12 December 2020

Goals of antihypertensive therapy

1 reference

12 December 2020

Evolution of blockade of the renin-angiotensin system

1 reference

12 December 2020

Valsartan/hydrochlorothiazide

1 reference

12 December 2020

A review of eprosartan pharmacokinetic and pharmacodynamic drug interaction studies

1 reference

12 December 2020

First-line treatment of hypertension: from monotherapy to fixed low-dose combination therapy

1 reference

12 December 2020

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

12 December 2020

Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension

1 reference

12 December 2020

Clinical efficacy of eprosartan

1 reference

12 December 2020

Managing hypertension in general practice: can we do better?

1 reference

12 December 2020

First-line and combination treatment for hypertension

1 reference

12 December 2020

Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. Eprosartan Study Group.

1 reference

12 December 2020

A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide

1 reference

12 December 2020

Management of hypertension: the role of combination therapy

1 reference

12 December 2020

The multifactorial nature of hypertension: the greatest challenge for its treatment?

1 reference

12 December 2020

Combination therapy with diuretics: an evolution of understanding

1 reference

12 December 2020

Significance of chymase-dependent angiotensin II-forming pathway in the development of vascular proliferation

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566

1 reference

12 December 2020

Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials

1 reference

12 December 2020

Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group

1 reference

12 December 2020

Chymase-dependent angiotensin II formation in human vascular tissue

1 reference

12 December 2020

Effect of eprosartan and enalapril in the treatment of elderly hypertensive patients: subgroup analysis of a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group

1 reference

12 December 2020

Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.

1 reference

12 December 2020

Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension

1 reference

12 December 2020

The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals.

1 reference

12 December 2020

Evidence for the efficacy of low-dose diuretic monotherapy

1 reference

12 December 2020

Eprosartan versus enalapril in elderly patients with hypertension: a double-blind, randomized trial

1 reference

12 December 2020

Renal implications of angiotensin receptor blockers

1 reference

12 December 2020

10.2165/00002018-200225080-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1040118799

0 references

1 reference